Site Map
Posts
- Category: Wp Feeds (continued)
- No Approval for Rifaximin in IBS
- No Benefit for Steroids in Allograft Renal Transplant (CME/CE)
- No Benefit From Ezetimibe in NASH (CME/CE)
- No Benefit Seen for Probiotics in Ulcerative Colitis
- No Change for Doc Pay: MedPac
- No Clear Winner in C. Difficile Battle (CME/CE)
- No Elevated Heart Risk in IBD
- No IBD Risk Seen with Acne Drug (CME/CE)
- No Increase in Intussusception With Rotavirus Vaccine (CME/CE, with video)
- No Increased IBD Risk With Cosentyx (CME/CE)
- No Mortality Benefit From Pentoxifylline in Alcoholic Hepatitis (CME/CE)
- No Single Reason for Readmission After GI Surgery (CME/CE)
- No Surgery for Appendicitis Passes Test in Kids
- No Survival Advantage in Pancreatic Ca With Metformin (CME/CE)
- No Survival Gain with Aspirin in Colon Cancer
- No Ties Between Early Antibiotics and T1D or Celiac Disease (CME/CE)
- No Tx Frontrunners in Colorectal Cancer Trials
- No Wheat or Barley on the Label? Be Careful, There Could Still Be Gluten
- Nodes Don't Add Up for Better Colon Cancer Staging (CME/CE)
- Non-Alcoholic Fatty Liver: Risk Factor for Hypertension? (CME/CE)
- Non-V600 BRAF Mutation Tied to Better CRC Prognosis (CME/CE)
- Nonsurgical Treatment of Rectal Cancer Questioned (CME/CE)
- Nontoxic Battery Promising for Ingestible Devices
- Norovirus Main Gastroenteritis Culprit in Kids (CME/CE)
- Norovirus Tied to Nursing Home Deaths (CME/CE)
- Norovirus Tied to Nursing Home Deaths (CME/CE)
- Norovirus Vax Cuts Severity of GI Symptoms
- Not Enough Funding in 'Cures' Bill, FDA Chief Warns
- Not Much to Show for Nation's High Cost of Care
- Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers
- Novel Biliary Stent Proves Long-Term Mettle
- Novel C. Diff Drug Questioned in FDA Staff Review
- Novel Drug Combo Succeeds Against Multiple HCV Genotypes (CME/CE)
- Novel Drug Eases Chronic Constipation (CME/CE)
- Novel Drug Offers Hope in Rare Liver Disease (CME/CE)
- Novel Drug Shows Promise in Gastric Cancer
- Novel Drug Works Against Hepatitis C
- Novel HCV Drug Can Double Response Rate (CME/CE)
- Novel HCV Drug Can Double Response Rate (CME/CE)
- Novel HCV Drug Combo Shines in CKD Patients (CME/CE)
- Novel Intestinal Sleeve Improves Weight and T2D Control In Real World
- Novel Medical Food Relieves Pouchitis (CME/CE)
- Novel NASH Agent Boosts Liver Scores (CME/CE)
- Novel Pepsin Test Better to ID Aspiration Reflux (CME/CE)
- Novel Sedation Agent for Colonoscopy Meets Phase III Endpoints
- Novel Tenofovir Drug OK'd for Hepatitis B
- Novel Tx for Hepatic Encephalopathy Works Fast
- Novel Ulcerative Colitis Tx Promising in Phase II Trial (CME/CE)
- NSAID Bleeding Risk: Smoke But No Fire
- NSAID-Related Anemia Doubles Arthritis Costs (CME/CE)
